Good evening :)
Veerhealth Care Ltd

Veerhealth Care Ltd

VEERHEALTH Share Price

BSE
49.980.08% (+0.04)
High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP

With a market cap of ₹99 cr, stock is ranked 3,277

Stock is 2.36x as volatile as Nifty

VEERHEALTH Stock Scorecard

Performance

High

The creamy layer - amongst the top performing stocks

Valuation

High

Seems to be overvalued vs the market average

Growth

Low

Lagging behind the market in financials growth

Profitability

High

Showing good signs of profitability & efficiency

Entry point

Avg

The stock is not in the overbought zone

Red flags

Low

No red flag found

How to use scorecard? Learn more

With a market cap of ₹99 cr, stock is ranked 3,277

Stock is 2.36x as volatile as Nifty

VEERHEALTH Performance & Key Metrics

VEERHEALTH Performance & Key Metrics

No LabelNo LabelPB RatioPB RatioDividend YieldDiv. Yield
64.504.36
Sector PESector PESector PBSector PBSector Div YldSctr Div Yld
47.205.920.48%

VEERHEALTH Analyst Ratings & Forecast

Analyst Ratings data is currently unavailable for this stock

Price Upside

Earnings Growth

Rev. Growth

VEERHEALTH Company Profile

Veerhealth Care is engaged in manufacturing and marketing research-based Ayurvedic medicines. The Company's product categories include Tablets, Syrups, Ointments, Powder, Oil and Toothpaste.

VEERHEALTH Similar Stocks (Peers)

Compare with peers Compare with peers 

VEERHEALTH Similar Stocks (Peers)

Compare with peers Compare with peers 
PE Ratio
38.40
38.40
1Y Return
11.45%
11.45%
Buy Reco %
93.33
93.33
PE Ratio
85.10
85.10
1Y Return
35.67%
35.67%
Buy Reco %
81.48
81.48
PE Ratio
22.96
22.96
1Y Return
10.70%
10.70%
Buy Reco %
55.56
55.56
PE Ratio
29.04
29.04
1Y Return
11.64%
11.64%
Buy Reco %
62.86
62.86
LAURUSLABS
PE Ratio
118.79
118.79
1Y Return
111.64%
111.64%
Buy Reco %
58.33
58.33
Compare with Peers

VEERHEALTH Sentiment Analysis

VEERHEALTH Sentiment Analysis

New
Crisp summary & key insights to decode earnings calls instantly

VEERHEALTH Stock Summary · June 2024

VeerHealth Care Limited demonstrated robust financial performance in Q4 FY '24, with total income reaching INR 1,461.29 lakhs and a notable EBITDA margin of 13.70%. The company is strategically expanding its global footprint, particularly in the U.S. market, where it anticipates generating INR 25 to 30 crores annually from exports, bolstered by recent FDA registrations. While aiming for a turnover of INR 100 crores by March 2027, it plans to enhance its product offerings and e-commerce presence, despite facing challenges such as declining promoter shareholding. A strong commitment to quality and compliance, alongside operational upgrades, positions the company favorably for future growth and market confidence.

VEERHEALTH Stock Growth Drivers
VEERHEALTH Stock Growth Drivers
7
  • Regulatory Milestones and Market Entry

    VeerHealth Care Limited has achieved significant regulatory milestones, including the allocation of a US FDA

  • Strong Financial Performance

    In FY '24, VeerHealth Care reported total income of INR 1,461.29 lakhs and an EBITDA

VEERHEALTH Stock Challenges
VEERHEALTH Stock Challenges
3
  • Decline in Promoter Shareholding

    The company's promoter shareholding has decreased significantly from 44.36% in December 2022 to 30% currently.

  • Reduction in Contract Manufacturing Revenue

    The company anticipates a decrease in revenue from contract manufacturing, which currently accounts for 55%

VEERHEALTH Forecast

VEERHEALTH Forecasts

empty forecast

Forecast data is currently unavailable

Forecast data is currently unavailable

Price

Price Upside

Revenue

Revenue Growth

Earnings

Earnings Per Share

VEERHEALTH

VEERHEALTH

Income

Balance Sheet

Cash Flow

VEERHEALTH Income Statement

VEERHEALTH Income Statement

Loading...

Quartermar 2024jun 2024sep 2024dec 2024mar 2025jun 2025sep 2025dec 2025mar 2026jun 2026
Total Revenue3.532.425.394.026.055.144.216.9716.9825.09
Operating & Other expensessubtract3.192.084.663.685.784.523.456.0216.3423.02
Depreciation/Amortizationsubtract0.180.190.200.250.260.280.310.350.350.36
Interest & Other Itemssubtract0.000.000.110.010.140.100.100.100.110.23
Taxes & Other Itemssubtract0.710.030.120.00-0.030.000.090.090.530.25
EPS-0.260.060.150.04-0.050.120.130.20-0.180.61

VEERHEALTH Company Updates

Annual Report and Investor Presentation updates mentioned here are as reported by the company to the exchange
FY 2026FY 2026

Annual report

PDF
FY 2025FY 2025

Annual report

PDF
FY 2024FY 2024

Annual report

PDF
FY 2023FY 2023

Annual report

PDF
FY 2022FY 2022

Annual report

PDF
FY 2021FY 2021

Annual report

PDF
FY 2020FY 2020

Annual report

PDF
FY 2019FY 2019

Annual report

PDF
FY 2018FY 2018

Annual report

PDF
FY 2017FY 2017

Annual report

PDF
 

VEERHEALTH Stock Peers

VEERHEALTH Past Performance & Peer Comparison

VEERHEALTH Past Performance & Peer Comparison

Comparing 3 stocks from 
Health CarePharmaceuticals

Loading...

StockPE RatioPE RatioPB RatioPB RatioDiv. YieldDividend Yield
Veerhealth Care Ltd181.774.36
Sun Pharmaceutical Industries Ltd38.405.260.87%
Torrent Pharmaceuticals Ltd85.1010.470.70%
Zydus Lifesciences Ltd22.963.910.09%

VEERHEALTH Stock Price Comparison

Compare VEERHEALTH with any stock or ETF
Compare VEERHEALTH with any stock or ETF
VEERHEALTH
Loading...

VEERHEALTH Holdings

VEERHEALTH Shareholdings

VEERHEALTH Promoter Holdings Trend

VEERHEALTH Promoter Holdings Trend

Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

VEERHEALTH Institutional Holdings Trend

VEERHEALTH Institutional Holdings Trend

Decreased Total Retail Holding
Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.

In last 3 months, retail holding in the company has decreased by 3.98%

Foreign Institutional Holding
Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock

In last 3 months, foreign institutional holding of the company has almost stayed constant

Tickertape Separator

VEERHEALTH Shareholding Pattern

VEERHEALTH Shareholding Pattern

Retail and OthersForeign InstitutionsOther Domestic InstitutionsMutual FundsTotal Promoter Holding31.91%0.00%0.00%0.00%68.09%

Sep 2025

Dec 2025

Mar 2026

Jun 2026

VEERHEALTH Shareholding History

VEERHEALTH Shareholding History

MarJunSepDec '25MarJun0.00%0.00%0.00%0.00%0.00%0.00%

VEERHEALTH Insider Trades & Bulk Stock Deals

VEERHEALTH Insider Trades & Bulk Stock Deals

Loading...

smallcases containing VEERHEALTH stock

smallcases containing VEERHEALTH stock

Looks like this stock is not in any smallcase yet.

VEERHEALTH Events

VEERHEALTH Events

VEERHEALTH Dividend Trend

No Dividends
Dividends are the portion of earnings that a company distributes to all its shareholders every year

VEERHEALTH has not given any dividends in last 5 years

Dividends

Corp. Actions

Announcements

Legal Orders

VEERHEALTH Dividend Trend

No Dividends
Dividends are the portion of earnings that a company distributes to all its shareholders every year

VEERHEALTH has not given any dividends in last 5 years

VEERHEALTH Dividends

VEERHEALTH Dividends

Hmm, looks like data is unavailable here. Please come back after some time

VEERHEALTH Stock News & Opinions

VEERHEALTH Stock News & Opinions

Spotlight
Spotlight
Veerhealth Care Limited secures Rs 10.08 lakh purchase order for oral care products

Veerhealth Care Limited announced it has entered into a supply agreement with an Indo-Canadian joint venture, a global manufacturer of luxury amenities, to manufacture and supply oral care products for the Indian, USA, and Canada markets. The company has received its first purchase order for oral care products valued at Rs 10,07,800, to be fulfilled within 45 days, and the order is expected to be executed domestically.

1 week agoCapital Market - Live
Spotlight
Spotlight
Veerhealth Care Ltd. secures Rs 436.99 lakh order from an Indian FMCG company for skincare products

Veerhealth Care Ltd. announced it has received an order from an Indian Fast Moving Consumer Goods (FMCG) company for skincare products valued at Rs 436.99 Lakhs, representing a significant opportunity for growth in turnover. The order, for the supply of face care products from a domestic entity, is to be executed within 45 days, and does not involve any related party transactions.

2 weeks agoCapital Market - Live
Spotlight
Spotlight
Veerhealth Care Ltd. secures Rs 526.84 lakh order from an Indian FMCG company for skincare products

Veerhealth Care Ltd. announced it has received an order from an Indian Fast Moving Consumer Goods (FMCG) company for skincare products valued at Rs 526.84 Lakhs. The order, which requires execution within 45 days, represents a significant opportunity for the company and is expected to contribute to increased turnover. The order is for the supply of face care products from a domestic entity, and Veerhealth Care confirmed that neither promoters nor group companies have any interest in the awarding entity, and the transaction does not constitute a related party transaction.

1 month agoCapital Market - Live
Corporate
Corporate
Veerhealth Care wins order of Rs 15.73 cr from Sudan

Veerhealth Care has secured an export order worth Rs 15.73 crore for manufacture and supply of Gripe Water from Sudan. This export order marks the Company's first strategic entry into the Sudan market, expanding its global presence in the pediatric and wellness care segment.

1 month agoCapital Market - Live
Earnings
Earnings
Veerhealth Care reports standalone net loss of Rs 0.35 crore in the March 2026 quarter

Net Loss of Veerhealth Care reported to Rs 0.35 crore in the quarter ended March 2026 as against net loss of Rs 0.10 crore during the previous quarter ended March 2025. Sales rose 198.22% to Rs 16.76 crore in the quarter ended March 2026 as against Rs 5.62 crore during the previous quarter ended March 2025. For the full year,net profit rose 38.46% to Rs 0.54 crore in the year ended March 2026 as against Rs 0.39 crore during the previous year ended March 2025. Sales rose 92.53% to Rs 32.48 crore in the year ended March 2026 as against Rs 16.87 crore during the previous year ended March 2025. ParticularsQuarter EndedYear EndedMar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var. Sales16.765.62 198 32.4816.87 93 OPM %4.36-2.85 -7.544.56 - PBDT0.840.13 546 2.851.53 86 PBT0.49-0.13 LP 1.560.62 152 NP-0.35-0.10 -250 0.540.39 38 Powered by Capital Market - Live

3 months agoCapital Market - Live
Corporate
Corporate
Veerhealth Care to discuss result

Veerhealth Care will hold a meeting of the Board of Directors of the Company on 30 May 2026.

3 months agoCapital Market - Live
Corporate
Corporate
Veerhealth Care secures export order of Rs 1.43 cr

Veerhealth Care has received a repeat order from New York -based Company for personal care products aggregating to an accepted value of $1,51,200 (approximately Rs 1.43 crore).

4 months agoCapital Market - Live
Corporate
Corporate
Veerhealth Care wins order of Rs 6.15 cr

Veerhealth Care has received an order of Rs 6.15 crore from a domestic FMCG company for supply of face care products.

5 months agoCapital Market - Live
Corporate
Corporate
Veerhealth Care announces board meeting date

Veerhealth Care will hold a meeting of the Board of Directors of the Company on 28 March 2026.Powered by Capital Market - Live

6 months agoCapital Market - Live
Corporate
Corporate
Veerhealth Care receives order worth Rs 5.50 cr

Veerhealth Care has received order from one of India's Fast Moving Consumer Goods (FMCG) company for personal care products for the accepted value of Rs 5.50 crore. Powered by Capital Market - Live

6 months agoCapital Market - Live

Frequently asked questions

Frequently asked questions

  1. The share price of VEERHEALTH as on 18th September 2026 is ₹49.98. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.

  2. The past returns of Veerhealth Care Ltd (VEERHEALTH) share are
    • Past 1 week: -1.30%
    • Past 1 month: 2.00%
    • Past 3 months: 72.38%
    • Past 6 months: 149.95%
    • Past 1 year: 176.95%
    • Past 3 years: 143.73%
    • Past 5 years: 941.46%

  3. Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Veerhealth Care Ltd (VEERHEALTH) is ₹99.97 Cr as of 18th September 2026.

  4. The 52-week high of Veerhealth Care Ltd (VEERHEALTH) is ₹52 and the 52-week low is ₹16.70.

  5. The P/E (price-to-earnings) ratio of Veerhealth Care Ltd (VEERHEALTH) is 181.77. The P/B (price-to-book) ratio is 4.36.

  6. Veerhealth Care Ltd (VEERHEALTH) belongs to the Health Care sector & Pharmaceuticals sub-sector.

  7. You can directly buy Veerhealth Care Ltd (VEERHEALTH) shares on Tickertape. Simply sign up, connect your demat account and place your order.